Cardioprotection against reperfusion injury is maximal with only two minutes of sevoflurane administration in rats

Canadian Journal of Anesthesia

Volumn 50, Issue 9, 2003, Pages 940-945

  Obal, Detlef ^a   Scharbatke, Horst ^a   Barthel, Holger ^a   Preckel, Benedikt ^a   Müllenheim, Jost ^a   Schlack, Wolgang ^a  

^a Universitaklinikum Dusseldorf   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CHLORALOSE; SEVOFLURANE; TRIPHENYLTETRAZOLIUM;

ANIMAL EXPERIMENT; ANIMAL MODEL; AORTA PRESSURE; ARTICLE; CONCENTRATION (PARAMETERS); CONFIDENCE INTERVAL; CONTROLLED STUDY; HEART INFARCTION; HEART INFARCTION SIZE; HEART LEFT VENTRICLE DP-DT; HEART LEFT VENTRICLE PRESSURE; HEART MUSCLE REPERFUSION; HEART PROTECTION; IN VIVO STUDY; MEAN ARTERIAL PRESSURE; MINIMUM LUNG ALVEOLUS CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; RAT; REPERFUSION INJURY; TIME;

EID: 0942288007     PISSN: 0832610X     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03018744     Document Type: Article

References (27)

1. Kato R, Foex P. Myocardial protection by anesthetic agents against ischemia-reperfusion injury: an update for anesthesiologists. Can J Anesth 2002; 49: 777-91.
2. Schlack W, Preckel B, Stunneck D, Thämer V. Effects of halothane, enflurane, isoflurane, sevoflurane and desflurane on myocardial reperfusion injury in the isolated rat heart. Br J Anaesth 1998; 81: 913-9.
3. Preckel B, Thämer V, Schlack W. Beneficial effects of sevoflurane and desflurane against myocardial reperfusion injury after cardioplegic arrest. Can J Anesth 1999; 46: 1076-81.
4. Preckel B, Schlack W, Comfere T, Obal D, Barthel H, Thämer V. Effects of enflurane, isoflurane, sevoflurane and desflurane on reperfusion injury after regional myocardial ischaemia in the rabbit heart in vivo. Br J Anaesth 1998; 81: 905-12.
5. Obal D, Preckel B, Scharbatke H, et al. One MAC of sevoflurane provides protection against reperfusion injury in the rat heart in vivo. Br J Anaesth 2001; 87: 905-11.
6. Siegmund B, Klietz T, Schwartz P, Piper HM. Temporary contractile blockade prevents hypercontracture in anoxic-reoxygenated cardiomyocytes. Am J Physiol 1991; 260: H426-35.
7. Siegmund B, Schlack W, Ladilov YV, Balser C, Piper HM. Halothane protects cardiomyocytes against reoxygenation-induced hypercontracture. Circulation 1997; 96: 4372-9.
8. Conzen PF, Vollmar B, Habazettl H, Frink EJ, Peter K, Messmer K. Systemic and regional hemodynamics of isoflurane and sevoflurane in rats. Anesth Analg 1992; 74: 79-88.
9. Jennings RB, Yellon DM. Reperfusion injury: definitions and historical background. In: Yellon DM, Jennings RB (Eds.). Myocardial Protection: The Pathophysiology of Reperfusion and Reperfusion Injury. New York: Raven Press; 1992: 1-11.
10. Schlack W, Hollmann M, Stunneck J, Thämer V. Effect of halothane on myocardial reoxygenation injury in the isolated rat heart. Br J Anaesth 1996; 76: 860-7.
11. Schlack W, Preckel B, Barthel H, Obal D, Thämer V. Halothane reduces reperfusion injury after regional ischaemia in the rabbit heart in vivo. Br J Anaesth 1997; 79: 88-96.
12. Ebel D, Preckel B, You A, Mullenheim J, Schlack W, Thämer V. Cardioprotection by sevoflurane against reperfusion injury after cardioplegic arrest in the rat is independent of three types of cardioplegia. Br J Anaesth 2002; 88: 828-35.
13. Theroux P. Myocardial cell protection. A challenging time for action and a challenging time for clinical research (Editorial). Circulation 2000; 101: 2874-6.
14. Horwitz LD, Kong Y, Robertson AD. Timing of treatment for myocardial reperfusion injury. J Cardiovasc Pharmacol 1999; 33: 19-29.
15. Kazama T, Ikeda K. Comparison of MAC and the rate of rise of alveolar concentration of sevoflurane with halothane and isoflurane in the dog. Anesthesiology 1988; 68: 435-7.
16. Hearse DJ, Humphrey SM, Chain EB. Abrupt reoxygenation of the anoxic potassium-arrested perfused rat heart: a study of myocardial enzyme release. J Mol Cell Cardiol 1973; 5: 395-407.
17. + exchange. Am J Physiol 1995; 268: H1531-9.
18. 2+ overload. Am J Physiol 1992; 263: H1262-9.
19. Shell WE, Sobel BE. Protection of jeopardized ischemic myocardium by reduction of ventricular afterload. N Engl J Med 1974; 291: 481-6.
20. Okamoto F, Allen BS, Buckberg GD, Bugyi H, Leaf J. Studies of controlled reperfusion after ischemia. XIV. Reperfusion conditions: importance of ensuring gentle versus sudden reperfusion during relief of coronary occlusion. J Thorac Cardiovasc Surg 1986; 92: 613-20.
21. Ambrosio G, Weisman HF, Mannisi JA, Becker LC. Progressive impairment of regional myocardial perfusion after initial restoration of postischemic blood flow. Circulation 1989; 80: 1846-61.
22. Rezkalla SH, Kloner RA. No-reflow phenomenon. Circulation 2002; 105: 656-62.
23. Camilleri JP, Joseph D, Fabiani JN, et al. Microcirculatory changes following early reperfusion in experimental myocardial infarction. Virchows Arch A Pathol Anat Histol 1976; 369: 315-33.
24. Belhomme D, Peynet J, Louzy M, Launay JM, Kitakaze M, Menasche P. Evidence for preconditioning by isoflurane in coronary artery bypass graft surgery. Circulation 1999; 100(suppl II): II340-4.
25. Haroun-Bizri S, Khoury SS, Chehab IR, Kassas CM, Baraka A. Does isoflurane optimize myocardial protection during cardiopulmonary bypass? J Cardiothorac Vasc Anesth 2001; 15: 418-21.
26. Mangano DT.. Perioperative cardiac morbidity. Anesthesiology 1990; 72: 153-84.
27. Badner NH, Knill RL, Brown JE, Novick TV, Gelb AW. Myocardial infarction after noncardiac surgery. Anesthesiology 1998; 88: 572-8.